Which medication is considered safe for treating influenza in pregnant women?

Oseltamivir is considered safe for treating influenza in pregnant women because it has a well-documented safety profile and effectiveness in managing the flu during pregnancy. Multiple studies have indicated that oseltamivir does not pose significant risks for maternal or fetal complications, making it the preferred antiviral medication in this population. Additionally, health organizations such as the Centers for Disease Control and Prevention (CDC) recommend oseltamivir as a first-line treatment for pregnant women diagnosed with influenza.

The other medications listed have associated concerns. Amantadine and rimantadine have been less favored due to safety concerns and limited effectiveness against circulating strains of the influenza virus. Zanamivir, while also an antiviral medication, is administered via inhalation and may present challenges in pregnant patients who have respiratory issues or are unable to use inhalational therapies safely and effectively. Thus, oseltamivir remains the most reliable option for treating influenza in pregnant individuals.